Highly specific and sensitive detection of Burkholderia pseudomallei genomic DNA by CRISPR-Cas12a

Detection of Burkholderia pseudomallei , a causative bacterium for melioidosis, remains a challenging undertaking due to long assay time, laboratory requirements, and the lack of specificity and sensitivity of many current assays. In this study, we are presenting a novel method that circumvents thos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS neglected tropical diseases 2022-08, Vol.16 (8), p.e0010659-e0010659
Hauptverfasser: Wongpalee, Somsakul Pop, Thananchai, Hathairat, Chewapreecha, Claire, Roslund, Henrik B., Chomkatekaew, Chalita, Tananupak, Warunya, Boonklang, Phumrapee, Pakdeerat, Sukritpong, Seng, Rathanin, Chantratita, Narisara, Takarn, Piyawan, Khamnoi, Phadungkiat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Detection of Burkholderia pseudomallei , a causative bacterium for melioidosis, remains a challenging undertaking due to long assay time, laboratory requirements, and the lack of specificity and sensitivity of many current assays. In this study, we are presenting a novel method that circumvents those issues by utilizing CRISPR-Cas12a coupled with isothermal amplification to identify B . pseudomallei DNA from clinical isolates. Through in silico search for conserved CRISPR-Cas12a target sites, we engineered the CRISPR-Cas12a to contain a highly specific spacer to B . pseudomallei , named crBP34. The crBP34-based detection assay can detect as few as 40 copies of B . pseudomallei genomic DNA while discriminating against other tested common pathogens. When coupled with a lateral flow dipstick, the assay readout can be simply performed without the loss of sensitivity and does not require expensive equipment. This crBP34-based detection assay provides high sensitivity, specificity and simple detection method for B . pseudomallei DNA. Direct use of this assay on clinical samples may require further optimization as these samples are complexed with high level of human DNA.
ISSN:1935-2735
1935-2727
1935-2735
DOI:10.1371/journal.pntd.0010659